Federal Register of Legislation - Australian Government

Primary content

This determination exercises delegated Ministerial discretion under section 99ACF of the National Health Act 1953 (the Act) for anniversary reductions for 66 brands of pharmaceutical items listed on the F1 formulary of the Pharmaceutical Benefit Scheme.
Administered by: Health
Registered 31 May 2018

 

 

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ACF(3) of the National Health Act 1953.

Dated     29     May 2018

 

 

 

 

 

 

 

 

 

LISA LA RANCE

 

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

 

 

 

1              Name of Determination

                This instrument is the National Health (June 1 2018 Anniversary statutory price reduction) (Exercise of Ministerial discretion) Determination 2018.  

2              Commencement

                This instrument commences on the day it is made.

3              Definition

 

              Note: A number of expressions used in this instrument are defined in Part VII the Act,

 

In this instrument:

  

   Act means the National Health Act 1953.

 

price reduction day has the same meaning as in section 99ACL of the Act.

4              Authority

 

This instrument is made under subsection 99ACF(3) of the Act.

5              Brand of pharmaceutical item not subject to a price reduction

 

                I determine, under paragraph 99ACF(3)(a) of the Act, that the approved ex-manufacturer price of each brand of pharmaceutical item specified in column 2  as an item in the table in Schedule 1 is not reduced under a provision mentioned in item 5 or 6 of the table in subsection 99ACF(1) of the Act, as appropriate, in relation to the price reduction day.

6              Brand of pharmaceutical item subject to a lower price reduction  than would otherwise apply

 

                I determine, under paragraph 99ACF(3)(b) of the Act, that the approved ex-manufacturer price of a brand of pharmaceutical item specified in column 2 of an item in the table in Schedule 2 is reduced under a provision mentioned in item 5 or 6 of the table in subsection 99ACF(1) of the Act, as appropriate, in relation to the price reduction day by the percentage specified in column 3 of the table item. 

            


Schedule 1 Brands of pharmaceutical items with approved ex-manufacturer price not reduced

 

Column 1

Column 2

Item

Brand of Pharmaceutical Item

 

Drug

Form

Manner of administration

Brand

1

Albendazole

Tablet 200 mg

Oral

Zentel

2

Albendazole

Tablet 400 mg

Oral

Eskazole

3

Atovaquone

Oral suspension 750 mg per 5 mL, 210 mL

Oral

Wellvone

4

Atropine

Injection containing atropine sulfate 600 micrograms in 1 mL

Injection

Pfizer Australia Pty Ltd

5

Auranofin

Capsule 3 mg

Oral

Ridaura

6

Benztropine

Injection containing benztropine mesylate 2mg in 2 mL

Injection

Benzatropine Injection

7

Chloramphenicol

Eye drops 5 mg per mL, 10 mL

Application to the Eye

Chlorsig

8

Cholestyramine

Sachets containing 4.7 g oral powder (equivalent to 4 g cholestyramine), 50

Oral

Questran Lite

9

Cortisone

Tablet containing cortisone acetate 25 mg

Oral

Cortate

10

Cortisone

Tablet containing cortisone acetate 5 mg

Oral

Cortate

11

Cyclophosphamide

Tablet 50 mg

Oral

Cycloblastin

12

Cytarabine

Injection 100 mg in 5 mL vial

Injection

Pfizer Australia Pty Ltd

13

Dantrolene

Capsule containing dantrolene sodium 25 mg

Oral

Dantrium

14

Dantrolene

Capsule containing dantrolene sodium 50 mg

Oral

Dantrium

15

Ethosuximide

Oral solution 250 mg per 5 mL, 200 mL

Oral

Zarontin

16

Flupenthixol decanoate

Oily I.M. injection 100 mg in 1 mL ampoule

Injection

Fluanxol Concentrated Depot

17

Flupenthixol decanoate

Oily I.M. injection 20 mg in 1 mL

Oral

Foltabs 500

18

Folic acid

Tablet 5 mg

Oral

Megafol 5

19

Folic acid

Tablet 500 micrograms

Oral

Foltabs 500

20

Folic acid

Tablet 500 micrograms

Oral

Megafol 0.5

21

Haloperidol

Tablet 5 mg

Oral

Serenace

22

Hydromorphone

Injection containing hydromorphone hydrochloride 10 mg in 1 mL

Injection

Dilaudid-HP

23

Hydromorphone

Injection containing hydromorphone hydrochloride 2 mg in 1 mL

Injection

Dilaudid

24

Hydromorphone

Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 473 mL

Oral

Dilaudid

25

Hydromorphone

Tablet containing hydromorphone hydrochloride 2 mg

Oral

Dilaudid

26

Hydromorphone

Tablet containing hydromorphone hydrochloride 4 mg

Oral

Dilaudid

27

Hydromorphone

Tablet containing hydromorphone hydrochloride 8 mg

Oral

Dilaudid

28

Lithium

Tablet containing lithium carbonate 250 mg

Oral

Lithicarb

29

Lithium

Tablet containing lithium carbonate 450 mg (slow release)

Oral

Quilonum SR

30

Mercaptopurine

Tablet 50 mg

Oral

Purinethol

31

Milk powder -- synthetic

Low calcium oral powder 400 g (Locasol)

Oral

Locasol

32

Nitrofurantoin

Capsule 100 mg

Oral

Macrodantin

33

Nitrofurantoin

Capsule 50 mg

Oral

Macrodantin

34

Phenytoin

Oral suspension 30 mg per 5 mL, 500 mL

Oral

Dilantin

35

Pneumococcal vaccine - polyvalent

Injection 0.5 mL (23 valent)

Injection

Pneumovax 23

36

Progesterone

Capsule 200 mg

Vaginal

Utrogestan

37

Progesterone

Pessary 100 mg

Vaginal

Oripro

38

Progesterone

Pessary 200 mg

Vaginal

Oripro

39

Reboxetine

Tablet 4 mg (as mesilate)

Oral

Edronax

40

Sirolimus

Oral solution 1 mg per mL, 60 mL

Oral

Rapamune

41

Thiamine

Tablet containing thiamine hydrochloride 100 mg

Oral

Betavit

42

Triglycerides - medium chain, formula

Oral powder 400 g (Monogen)

Oral

Monogen

43

Zuclopenthixol decanoate

Oily I.M. injection 200 mg in 1 mL

Injection

Clopixol Depot

 

Schedule 2Brands of pharmaceutical items with approved ex-manufacturer price reduced by a lower percentage than would otherwise apply

 

Column 1

Column 2

Column 3

Item

Brand of pharmaceutical item

Percentage

 

Drug

Form

Manner of administration

Brand

 

1

Amphotericin

Lozenge 10 mg

Oral

Fungilin

8.12%

2

Benzathine Benzylpenicillin

Injection 900 mg in 2.3 mL single use pre-filled syringe

Injection

Bicillin L-A

3.6%

3

Benzylpenicillin

Powder for injection 3 g (as sodium)

Injection

BenPen

7.28%

4

Benzylpenicillin

Powder for injection 600 mg (as sodium)

Injection

BenPen

7.54%

5

Chlorambucil

Tablet 2 mg

Oral

Leukeran

10.83%

6

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

Injection 0.5 mL in pre-filled syringe

Injection

ADT Booster

5.89%

7

Ethosuximide

Capsule 250 mg

Oral

Zarontin

9.50%

8

Glucagon

Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe

Injection

GlucaGen Hypokit

5.61%

9

Haloperidol

Oral solution 2 mg per mL, 100 mL

Oral

Serenace

9.28%

10

Haloperidol

Tablet 1.5 mg

Oral

Serenace

1.16%

11

Haloperidol

Tablet 500 micrograms

Oral

Serenace

3.77%

12

Heparin

Injection (preservative-free) 5,000 I.U. (as sodium) in 5 mL

Injection

Pfizer Australia Pty Ltd

0.61%

13

Heparin

Injection 5,000 units (as sodium) in 0.2 mL

Injection

Hospira Pty Limited

2.72%

14

Lignocaine

Injection containing lignocaine hydrochloride 50 mg in 5 mL

Injection

Pfizer Australia Pty Ltd

1.95%

15

Nafarelin

Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses

Nasal

Synarel

3.21%

16

Nystatin

Capsule 500,000 units

Oral

Nilstat

3.94%

17

Nystatin

Tablet 500,000 units

Oral

Nilstat

3.94%

18

Oestriol

Pessaries 500 micrograms, 15

Vaginal

Ovestin Ovula

12.75%

19

Oestriol

Vaginal cream 1 mg per g, 15 g

Application

Ovestin

5.81%

20

Warfarin

Tablet containing warfarin sodium 1 mg

Oral

Coumadin

5.64%

21

Warfarin

Tablet containing warfarin sodium 1 mg

Oral

Marevan

5.64%

22

Warfarin

Tablet containing warfarin sodium 2 mg

Oral

Coumadin

6.98%

23

Warfarin

Tablet containing warfarin sodium 3 mg

Oral

Marevan

4.77%